NASDAQ:RKDA - Nasdaq - US0390143032 - Common Stock - Currency: USD
NASDAQ:RKDA (2/24/2025, 8:00:01 PM)
3.929
-0.05 (-1.32%)
The current stock price of RKDA is 3.929 USD. In the past month the price decreased by -23.26%. In the past year, price increased by 42.87%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ADM | ARCHER-DANIELS-MIDLAND CO | 10.25 | 23.16B | ||
BG | BUNGE GLOBAL SA | 8.01 | 9.82B | ||
INGR | INGREDION INC | 12.26 | 8.40B | ||
DAR | DARLING INGREDIENTS INC | 22.76 | 6.26B | ||
FDP | FRESH DEL MONTE PRODUCE INC | 12.38 | 1.44B | ||
CRESY | CRESUD S.A.-SPONS ADR | N/A | 644.11M | ||
LMNR | LIMONEIRA CO | 38.49 | 410.60M | ||
LND | BRASILAGRO-CIA BRA - SPN ADR | 7.08 | 359.61M | ||
CHSCP | CHS INC - CHSINC 8 PERP | N/A | 344.05M | ||
CHSCO | CHS INC - CHSINC 7 7/8 PERP | N/A | 328.35M | ||
CHSCL | CHS INC - CHSINC 7 1/2 PERP | N/A | 321.35M | ||
CHSCN | CHS INC - CHSINC 7.1 PERP | N/A | 313.62M |
Arcadia Biosciences, Inc. is an agricultural biotechnology company, which engages in the development of agricultural products. The company is headquartered in Davis, California and currently employs 21 full-time employees. The company went IPO on 2015-05-15. The Company’s product portfolio includes Zola Coconut Water (Zola). Zola is a natural, 100% coconut water. Zola is a non-genetically modified organisms (Non-GMO) project verified and only contains 60 calories per serving. The company offers Zola in different varieties, such as Original, Slightly Sweetened; Original with Pulp, Slightly Sweetened; Espresso, Slightly Sweetened; Pineapple; Lime; and others. The recipe with Zola includes smoothies, desserts, cocktails and mocktails, and bowls.
ARCADIA BIOSCIENCES INC
202 Cousteau Place, Suite 105
Davis CALIFORNIA 85018 US
CEO: Matthew T. Plavan
Employees: 21
Company Website: https://arcadiabio.com/
Investor Relations: http://ir.arcadiabio.com/phoenix.zhtml?c=253946&p=irol-irhome
Phone: 15307567077
The current stock price of RKDA is 3.929 USD. The price decreased by -1.32% in the last trading session.
The exchange symbol of ARCADIA BIOSCIENCES INC is RKDA and it is listed on the Nasdaq exchange.
RKDA stock is listed on the Nasdaq exchange.
7 analysts have analysed RKDA and the average price target is 12.24 USD. This implies a price increase of 211.53% is expected in the next year compared to the current price of 3.929. Check the ARCADIA BIOSCIENCES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
ARCADIA BIOSCIENCES INC (RKDA) has a market capitalization of 5.34M USD. This makes RKDA a Nano Cap stock.
ARCADIA BIOSCIENCES INC (RKDA) currently has 21 employees.
ARCADIA BIOSCIENCES INC (RKDA) has a support level at 3.92. Check the full technical report for a detailed analysis of RKDA support and resistance levels.
The Revenue of ARCADIA BIOSCIENCES INC (RKDA) is expected to decline by -20% in the next year. Check the estimates tab for more information on the RKDA EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
RKDA does not pay a dividend.
ARCADIA BIOSCIENCES INC (RKDA) will report earnings on 2025-03-26, after the market close.
ARCADIA BIOSCIENCES INC (RKDA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-4.7).
The outstanding short interest for ARCADIA BIOSCIENCES INC (RKDA) is 0.55% of its float. Check the ownership tab for more information on the RKDA short interest.
ChartMill assigns a technical rating of 2 / 10 to RKDA. When comparing the yearly performance of all stocks, RKDA is one of the better performing stocks in the market, outperforming 94.32% of all stocks.
ChartMill assigns a fundamental rating of 3 / 10 to RKDA. While RKDA has a great health rating, there are worries on its profitability.
Over the last trailing twelve months RKDA reported a non-GAAP Earnings per Share(EPS) of -4.7. The EPS increased by 77.87% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | N/A | ||
ROA | -38.23% | ||
ROE | -56.64% | ||
Debt/Equity | 0 |
ChartMill assigns a Buy % Consensus number of 83% to RKDA. The Buy consensus is the average rating of analysts ratings from 7 analysts.
For the next year, analysts expect an EPS growth of 93.58% and a revenue growth -20% for RKDA